内容摘要：President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the comments Monday when signing an

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the comments Monday when signing an

Kennedy has said some of the CDC’s other work will be moved to a yet-to-be-created agency, the. He also has said that the cuts are designed to get rid of waste at a department that has seen its budget grow in recent years.

“Unfortunately, this extra spending and staff has not improved our nation’s health as a country,”in The New York Post. “Instead, it has only created more waste, administrative bloat and duplication.”Yet some health experts say the eliminated programs are not duplicative, and erasing them will leave Americans in the dark.

“If the U.S. is interested in making itself healthier again, how is it going to know, if it cancels the programs that helps us understand these diseases?” said Graham Mooney, a Johns Hopkins University public health historian.The core of the nation’s health surveillance is done by the CDC’s

. Relying on birth and death certificates, it generates information on birth rates, death trends and life expectancy. It also operates longstanding health surveys that provide basic data on obesity, asthma and other health issues.

The center has been barely touched in layoffs, and seems intact under current budget plans.The case is being considered in Texas by U.S. District Judge Matthew Kacsmaryk, a Trump nominee who once ruled in favor of halting approval for the drug.

Kacsmaryk’s original ruling came in a lawsuit filed by anti-abortion groups. It was narrowed by an appeals court before being tossed out by the Supreme Court, which found the plaintiffs lacked the legal right to sue.The three states later moved to revive the case, arguing they did have legal standing because access to the drug undermined their abortion laws.

But the Department of Justice attorneys said the states can’t just piggyback on the earlier lawsuit as a way to keep the case in Texas.Nothing is stopping the states from filing the lawsuit someplace else, attorney Daniel Schwei wrote, but the venue has to have some connection to the claims being made.